At 0 2 0 2 O
least 3 8 3 8 O
14 9 11 9 11 B-lower_bound
days 12 16 12 16 I-lower_bound
must 17 21 17 21 O
have 22 26 22 26 O
elapsed 27 34 27 34 O
after 35 40 35 40 O
receiving 41 50 41 50 O
pegfilgrastim 51 64 51 64 B-treatment

Biologic 0 8 65 73 B-treatment
( 9 10 74 75 I-treatment
anti 10 14 75 79 I-treatment
- 14 15 79 80 I-treatment
neoplastic 15 25 80 90 I-treatment
agent 26 31 91 96 I-treatment
): 31 33 96 98 I-treatment
At 34 36 99 101 O
least 37 42 102 107 O
7 43 44 108 109 B-lower_bound
days 45 49 110 114 I-lower_bound
must 50 54 115 119 O
have 55 59 120 124 O
elapsed 60 67 125 132 O
since 68 73 133 138 O
completion 74 84 139 149 O
of 85 87 150 152 O
therapy 88 95 153 160 B-treatment
with 96 100 161 165 I-treatment
a 101 102 166 167 I-treatment
biologic 103 111 168 176 I-treatment
agent 112 117 177 182 I-treatment

Clinically 0 10 183 193 O
significant 11 22 194 205 O
medical 23 30 206 213 B-chronic_disease
disorders 31 40 214 223 I-chronic_disease
that 41 45 224 228 O
could 46 51 229 234 O
compromise 52 62 235 245 O
the 63 66 246 249 O
ability 67 74 250 257 O
to 75 77 258 260 O
tolerate 78 86 261 269 O
protocol 87 95 270 278 O
therapy 96 103 279 286 B-treatment
or 104 106 287 289 O
that 107 111 290 294 O
would 112 117 295 300 O
interfere 118 127 301 310 O
with 128 132 311 315 O
the 133 136 316 319 O
study 137 142 320 325 O
procedures 143 153 326 336 O
or 154 156 337 339 O
results 157 164 340 347 O
history 165 172 348 355 O

Female 0 6 356 362 B-gender
participants 7 19 363 375 I-gender
of 20 22 376 378 O
childbearing 23 35 379 391 O
potential 36 45 392 401 O
can 46 49 402 405 B-pregnancy
not 49 52 405 408 I-pregnancy
be 53 55 409 411 I-pregnancy
pregnant 56 64 412 420 I-pregnancy
or 65 67 421 423 O
breast 68 74 424 430 O
- 74 75 430 431 O
feeding 75 82 431 438 O

Female 0 6 439 445 B-gender
patients 7 15 446 454 I-gender

For 0 3 455 458 O
Stratum 4 11 459 466 O
A 12 13 467 468 O
participants 14 26 469 481 O
, 26 27 481 482 O
histologic 28 38 483 493 O
confirmation 39 51 494 506 O
of 52 54 507 509 O
the 55 58 510 513 O
diagnosis 59 68 514 523 O
of 69 71 524 526 O
AT 72 74 527 529 B-cancer
/ 74 75 529 530 O
RT 75 77 530 532 B-cancer
or 78 80 533 535 O
MRT 81 84 536 539 B-cancer
may 85 88 540 543 O
be 89 91 544 546 O
from 92 96 547 551 O
the 97 100 552 555 O
original 101 109 556 564 O
diagnosis 110 119 565 574 O
or 120 122 575 577 O
at 123 125 578 580 O
the 126 129 581 584 O
time 130 134 585 589 O
of 135 137 590 592 O
recurrence 138 148 593 603 O
/ 148 149 603 604 O
progression 149 160 604 615 O

For 0 3 616 619 O
agents 4 10 620 626 O
that 11 15 627 631 O
have 16 20 632 636 O
known 21 26 637 642 O
adverse 27 34 643 650 O
events 35 41 651 657 O
occurring 42 51 658 667 O
beyond 52 58 668 674 O
7 59 60 675 676 B-upper_bound
days 61 65 677 681 I-upper_bound
after 66 71 682 687 I-upper_bound
administration 72 86 688 702 O
, 86 87 702 703 O
this 88 92 704 708 O
period 93 99 709 715 O
prior 100 105 716 721 O
to 106 108 722 724 O
enrollment 109 119 725 735 O
must 120 124 736 740 O
be 125 127 741 743 O
extended 128 136 744 752 O
beyond 137 143 753 759 O
the 144 147 760 763 O
time 148 152 764 768 O
during 153 159 769 775 O
which 160 165 776 781 O
adverse 166 173 782 789 O
events 174 180 790 796 O
are 181 184 797 800 O
known 185 190 801 806 O
to 191 193 807 809 O
occur 194 199 810 815 O

Hematopoietic 0 13 816 829 O
growth 14 20 830 836 O
factors 21 28 837 844 O
: 28 29 844 845 O
At 30 32 846 848 O
least 33 38 849 854 O
7 39 40 855 856 B-lower_bound
days 41 45 857 861 I-lower_bound
must 46 50 862 866 O
have 51 55 867 871 O
elapsed 56 63 872 879 O
since 64 69 880 885 O
the 70 73 886 889 O
completion 74 84 890 900 O
of 85 87 901 903 O
therapy 88 95 904 911 B-treatment
with 96 100 912 916 O
a 101 102 917 918 O
growth 103 109 919 925 O
factor 110 116 926 932 O

Intermittent 0 12 933 945 O
uses 13 17 946 950 O
of 18 20 951 953 O
antacids 21 29 954 962 B-treatment
or 30 32 963 965 O
H2 33 35 966 968 B-treatment
antagonists 36 47 969 980 I-treatment
are 48 51 981 984 O
allowed 52 59 985 992 O
while 60 65 993 998 O
patients 66 74 999 1007 O
are 75 78 1008 1011 O
on 79 81 1012 1014 O
dexamethasone 82 95 1015 1028 B-treatment

Known 0 5 1029 1034 O
gastrointestinal 6 22 1035 1051 B-chronic_disease
disease 23 30 1052 1059 I-chronic_disease
or 31 33 1060 1062 O
procedures 34 44 1063 1073 O
that 45 49 1074 1078 O
could 50 55 1079 1084 O
interfere 56 65 1085 1094 O
with 66 70 1095 1099 O
the 71 74 1100 1103 O
oral 75 79 1104 1108 O
absorption 80 90 1109 1119 O
or 91 93 1120 1122 O
tolerance 94 103 1123 1132 O
of 104 106 1133 1135 O
alisertib 107 116 1136 1145 B-treatment

Known 0 5 1146 1151 O
history 6 13 1152 1159 O
of 14 16 1160 1162 O
uncontrolled 17 29 1163 1175 O
sleep 30 35 1176 1181 B-chronic_disease
apnea 36 41 1182 1187 I-chronic_disease
syndrome 42 50 1188 1196 I-chronic_disease
or 51 53 1197 1199 O
other 54 59 1200 1205 O
conditions 60 70 1206 1216 O
that 71 75 1217 1221 O
could 76 81 1222 1227 O
result 82 88 1228 1234 O
in 89 91 1235 1237 O
excessive 92 101 1238 1247 O
daytime 102 109 1248 1255 O
sleepiness 110 120 1256 1266 O
, 120 121 1266 1267 O
such 122 126 1268 1272 O
as 127 129 1273 1275 O
severe 130 136 1276 1282 O
chronic 137 144 1283 1290 B-chronic_disease
obstructive 145 156 1291 1302 I-chronic_disease
pulmonary 157 166 1303 1312 I-chronic_disease
disease 167 174 1313 1320 I-chronic_disease
or 175 177 1321 1323 O
a 178 179 1324 1325 O
requirement 180 191 1326 1337 O
for 192 195 1338 1341 O
supplemental 196 208 1342 1354 O
oxygen 209 215 1355 1361 O

Live 0 4 1362 1366 B-clinical_variable
expectancy 5 15 1367 1377 I-clinical_variable
> 16 17 1378 1379 O
8 17 18 1379 1380 B-lower_bound
weeks 19 24 1381 1386 I-lower_bound

Monoclonal 0 10 1387 1397 B-treatment
antibodies 11 21 1398 1408 I-treatment
: 21 22 1408 1409 O
At 23 25 1410 1412 O
least 26 31 1413 1418 O
3 32 33 1419 1420 B-lower_bound
half 34 38 1421 1425 I-lower_bound
- 38 39 1425 1426 I-lower_bound
lives 39 44 1426 1431 I-lower_bound
must 45 49 1432 1436 O
have 50 54 1437 1441 O
elapsed 55 62 1442 1449 O
since 63 68 1450 1455 O
prior 69 74 1456 1461 B-treatment
therapy 75 82 1462 1469 I-treatment
that 83 87 1470 1474 O
included 88 96 1475 1483 O
a 97 98 1484 1485 O
monoclonal 99 109 1486 1496 B-treatment
antibody 110 118 1497 1505 I-treatment

Myelosuppressive 0 16 1506 1522 B-treatment
chemotherapy 17 29 1523 1535 I-treatment
: 29 30 1535 1536 O
Patient 31 38 1537 1544 O
has 39 42 1545 1548 O
not 43 46 1549 1552 O
received 47 55 1553 1561 O
myelosuppressive 56 72 1562 1578 B-treatment
chemotherapy 73 85 1579 1591 I-treatment
within 86 92 1592 1598 O
3 93 94 1599 1600 B-upper_bound
weeks 95 100 1601 1606 I-upper_bound
of 101 103 1607 1609 O
enrollment 104 114 1610 1620 O
onto 115 119 1621 1625 O
this 120 124 1626 1630 O
study 125 130 1631 1636 O
( 131 132 1637 1638 O
4 132 133 1638 1639 B-lower_bound
and 134 137 1640 1643 O
6 138 139 1644 1645 B-upper_bound
weeks 140 145 1646 1651 I-upper_bound
if 146 148 1652 1654 O
prior 149 154 1655 1660 B-treatment
temozolomide 155 167 1661 1673 I-treatment
and 168 171 1674 1677 O
nitrosourea 172 183 1678 1689 B-treatment
, 183 184 1689 1690 O
respectively 185 197 1691 1703 O
) 197 198 1703 1704 O

Myocardial 0 10 1705 1715 B-chronic_disease
infarction 11 21 1716 1726 I-chronic_disease
within 22 28 1727 1733 O
6 29 30 1734 1735 B-upper_bound
months 31 37 1736 1742 I-upper_bound
prior 38 43 1743 1748 I-upper_bound
to 44 46 1749 1751 O
enrollment 47 57 1752 1762 O
or 58 60 1763 1765 O
New 61 64 1766 1769 B-clinical_variable
York 65 69 1770 1774 I-clinical_variable
Heart 70 75 1775 1780 I-clinical_variable
Association 76 87 1781 1792 I-clinical_variable
Class 88 93 1793 1798 B-lower_bound
III 94 97 1799 1802 I-lower_bound
or 98 100 1803 1805 O
IV 101 103 1806 1808 B-upper_bound
heart 104 109 1809 1814 B-chronic_disease
failure 110 117 1815 1822 I-chronic_disease
, 117 118 1822 1823 O
uncontrolled 119 131 1824 1836 B-chronic_disease
angina 132 138 1837 1843 I-chronic_disease
, 138 139 1843 1844 O
severe 140 146 1845 1851 O
uncontrolled 147 159 1852 1864 O
ventricular 160 171 1865 1876 B-chronic_disease
arrhythmias 172 183 1877 1888 I-chronic_disease
, 183 184 1888 1889 O
or 185 187 1890 1892 O
electrocardiographic 188 208 1893 1913 B-treatment
evidence 209 217 1914 1922 O
of 218 220 1923 1925 O
acute 221 226 1926 1931 O
ischemia 227 235 1932 1940 B-chronic_disease
or 236 238 1941 1943 O
active 239 245 1944 1950 O
conduction 246 256 1951 1961 O
system 257 263 1962 1968 O
abnormalities 264 277 1969 1982 O

No 0 2 1983 1985 O
previous 3 11 1986 1994 B-treatment
anticancer 12 22 1995 2005 I-treatment
therapy 23 30 2006 2013 I-treatment
( 31 32 2014 2015 O
radiation 32 41 2015 2024 B-treatment
therapy 42 49 2025 2032 I-treatment
or 50 52 2033 2035 O
chemotherapy 53 65 2036 2048 B-treatment
) 65 66 2048 2049 O
other 67 72 2050 2055 O
than 73 77 2056 2060 O
the 78 81 2061 2064 O
use 82 85 2065 2068 O
of 86 88 2069 2071 O
corticosteroids 89 104 2072 2087 B-treatment

Other 0 5 2088 2093 O
severe 6 12 2094 2100 O
acute 13 18 2101 2106 O
or 19 21 2107 2109 O
chronic 22 29 2110 2117 O
medical 30 37 2118 2125 O
or 38 40 2126 2128 O
psychiatric 41 52 2129 2140 B-chronic_disease
condition 53 62 2141 2150 I-chronic_disease
, 62 63 2150 2151 O
including 64 73 2152 2161 O
uncontrolled 74 86 2162 2174 O
diabetes 87 95 2175 2183 B-chronic_disease
, 95 96 2183 2184 O
malabsorption 97 110 2185 2198 B-chronic_disease
, 110 111 2198 2199 O
resection 112 121 2200 2209 B-treatment
of 122 124 2210 2212 I-treatment
the 125 128 2213 2216 I-treatment
pancreas 129 137 2217 2225 I-treatment
or 138 140 2226 2228 O
upper 141 146 2229 2234 B-treatment
small 147 152 2235 2240 I-treatment
- 152 153 2240 2241 I-treatment
bowel 153 158 2241 2246 I-treatment
, 158 159 2246 2247 O
or 160 162 2248 2250 O
requirement 163 174 2251 2262 O
for 175 178 2263 2266 O
pancreatic 179 189 2267 2277 O
enzymes 190 197 2278 2285 O
, 197 198 2285 2286 O
any 199 202 2287 2290 O
condition 203 212 2291 2300 O
that 213 217 2301 2305 O
would 218 223 2306 2311 O
modify 224 230 2312 2318 O
the 231 234 2319 2322 O
absorption 235 245 2323 2333 O
of 246 248 2334 2336 O
oral 249 253 2337 2341 B-treatment
medications 254 265 2342 2353 I-treatment
in 266 268 2354 2356 O
the 269 272 2357 2360 O
small 273 278 2361 2366 O
bowel 279 284 2367 2372 O
or 285 287 2373 2375 O
any 288 291 2376 2379 O
laboratory 292 302 2380 2390 O
abnormality 303 314 2391 2402 O
that 315 319 2403 2407 O
may 320 323 2408 2411 O
increase 324 332 2412 2420 O
the 333 336 2421 2424 O
risk 337 341 2425 2429 O
associated 342 352 2430 2440 O
with 353 357 2441 2445 O
study 358 363 2446 2451 O
participation 364 377 2452 2465 O
or 378 380 2466 2468 O
investigational 381 396 2469 2484 B-treatment
product 397 404 2485 2492 I-treatment
administration 405 419 2493 2507 O
or 420 422 2508 2510 O
that 423 427 2511 2515 O
may 428 431 2516 2519 O
interfere 432 441 2520 2529 O
with 442 446 2530 2534 O
the 447 450 2535 2538 O
interpretation 451 465 2539 2553 O
of 466 468 2554 2556 O
study 469 474 2557 2562 O
results 475 482 2563 2570 O
and 483 486 2571 2574 O
, 486 487 2574 2575 O
in 488 490 2576 2578 O
the 491 494 2579 2582 O
judgment 495 503 2583 2591 O
of 504 506 2592 2594 O
the 507 510 2595 2598 O
investigator 511 523 2599 2611 O
, 523 524 2611 2612 O
would 525 530 2613 2618 O
make 531 535 2619 2623 O
the 536 539 2624 2627 O
patient 540 547 2628 2635 O
inappropriate 548 561 2636 2649 O
for 562 565 2650 2653 O
enrollment 566 576 2654 2664 O
in 577 579 2665 2667 O
this 580 584 2668 2672 O
study 585 590 2673 2678 O

Patient 0 7 2679 2686 O
has 8 11 2687 2690 O
fully 12 17 2691 2696 O
recovered 18 27 2697 2706 O
from 28 32 2707 2711 O
the 33 36 2712 2715 O
acute 37 42 2716 2721 O
toxic 43 48 2722 2727 O
effects 49 56 2728 2735 O
of 57 59 2736 2738 O
chemotherapy 60 72 2739 2751 B-treatment
, 72 73 2751 2752 O
immunotherapy 74 87 2753 2766 B-treatment
, 87 88 2766 2767 O
or 89 91 2768 2770 O
radiation 92 101 2771 2780 B-treatment
therapy 102 109 2781 2788 I-treatment

Patients 0 8 2789 2797 O
may 9 12 2798 2801 O
not 13 16 2802 2805 O
have 17 21 2806 2810 O
previously 22 32 2811 2821 O
received 33 41 2822 2830 O
alisertib 42 51 2831 2840 B-treatment

Patients 0 8 2841 2849 O
must 9 13 2850 2854 O
be 14 16 2855 2857 O
< 17 18 2858 2859 O
22 19 21 2860 2862 B-upper_bound
years 22 27 2863 2868 I-upper_bound
of 28 30 2869 2871 O
age 31 34 2872 2875 B-age
at 35 37 2876 2878 O
time 38 42 2879 2883 O
of 43 45 2884 2886 O
diagnosis 46 55 2887 2896 O
( 56 57 2897 2898 O
e.g. 57 61 2898 2902 O
, 61 62 2902 2903 O
eligible 63 71 2904 2912 O
until 72 77 2913 2918 O
22nd 78 82 2919 2923 O
birthday 83 91 2924 2932 O
) 91 92 2932 2933 O

Patients 0 8 2934 2942 O
must 9 13 2943 2947 O
begin 14 19 2948 2953 O
treatment 20 29 2954 2963 B-treatment
as 30 32 2964 2966 O
outlined 33 41 2967 2975 O
in 42 44 2976 2978 O
the 45 48 2979 2982 O
protocol 49 57 2983 2991 O
within 58 64 2992 2998 O
42 65 67 2999 3001 B-upper_bound
days 68 72 3002 3006 I-upper_bound
of 73 75 3007 3009 O
definitive 76 86 3010 3020 O
surgery 87 94 3021 3028 B-treatment
( 95 96 3029 3030 O
day 96 99 3030 3033 O
of 100 102 3034 3036 O
surgery 103 110 3037 3044 O
is 111 113 3045 3047 O
day 114 117 3048 3051 O
0 118 119 3052 3053 O
; 119 120 3053 3054 O
definitive 121 131 3055 3065 O
surgery 132 139 3066 3073 O
includes 140 148 3074 3082 O
last 149 153 3083 3087 B-treatment
surgery 154 161 3088 3095 I-treatment
to 162 164 3096 3098 O
resect 165 171 3099 3105 O
residual 172 180 3106 3114 B-cancer
tumor 181 186 3115 3120 I-cancer
) 186 187 3120 3121 O

Patients 0 8 3122 3130 O
must 9 13 3131 3135 O
begin 14 19 3136 3141 O
treatment 20 29 3142 3151 B-treatment
within 30 36 3152 3158 O
42 37 39 3159 3161 B-upper_bound
days 40 44 3162 3166 I-upper_bound
of 45 47 3167 3169 O
definitive 48 58 3170 3180 B-treatment
surgery 59 66 3181 3188 I-treatment
( 67 68 3189 3190 O
day 68 71 3190 3193 O
of 72 74 3194 3196 O
surgery 75 82 3197 3204 O
is 83 85 3205 3207 O
day 86 89 3208 3211 O
0 90 91 3212 3213 O
; 91 92 3213 3214 O
definitive 93 103 3215 3225 O
surgery 104 111 3226 3233 O
includes 112 120 3234 3242 O
repeat 121 127 3243 3249 O
surgeries 128 137 3250 3259 B-treatment
to 138 140 3260 3262 O
resect 141 147 3263 3269 O
residual 148 156 3270 3278 B-cancer
tumor 157 162 3279 3284 I-cancer
) 162 163 3284 3285 O

Patients 0 8 3286 3294 O
of 9 11 3295 3297 O
childbearing 12 24 3298 3310 O
or 25 27 3311 3313 O
child 28 33 3314 3319 O
fathering 34 43 3320 3329 O
potential 44 53 3330 3339 O
must 54 58 3340 3344 O
be 59 61 3345 3347 O
willing 62 69 3348 3355 O
to 70 72 3356 3358 O
use 73 76 3359 3362 B-contraception_consent
a 77 78 3363 3364 I-contraception_consent
medically 79 88 3365 3374 I-contraception_consent
acceptable 89 99 3375 3385 I-contraception_consent
form 100 104 3386 3390 I-contraception_consent
of 105 107 3391 3393 I-contraception_consent
birth 108 113 3394 3399 I-contraception_consent
control 114 121 3400 3407 I-contraception_consent
, 121 122 3407 3408 O
which 123 128 3409 3414 O
includes 129 137 3415 3423 O
abstinence 138 148 3424 3434 B-contraception_consent
during 149 155 3435 3441 O
study 156 161 3442 3447 O
treatment 162 171 3448 3457 O
and 172 175 3458 3461 O
12 176 178 3462 3464 B-upper_bound
months 179 185 3465 3471 I-upper_bound
after 186 191 3472 3477 I-upper_bound
the 192 195 3478 3481 O
last 196 200 3482 3486 O
dose 201 205 3487 3491 O
of 206 208 3492 3494 O
alisertib 209 218 3495 3504 B-treatment

Patients 0 8 3505 3513 O
who 9 12 3514 3517 O
are 13 16 3518 3521 O
receiving 17 26 3522 3531 O
other 27 32 3532 3537 O
investigational 33 48 3538 3553 B-treatment
drugs 49 54 3554 3559 I-treatment
14 55 57 3560 3562 B-upper_bound
or 58 60 3563 3565 O
fewer 61 66 3566 3571 O
days 67 71 3572 3576 O
before 72 78 3577 3583 O
enrollment 79 89 3584 3594 O

Patients 0 8 3595 3603 O
who 9 12 3604 3607 O
are 13 16 3608 3611 O
unable 17 23 3612 3618 O
to 24 26 3619 3621 O
walk 27 31 3622 3626 O
because 32 39 3627 3634 O
of 40 42 3635 3637 O
paralysis 43 52 3638 3647 B-chronic_disease
, 52 53 3647 3648 O
but 54 57 3649 3652 O
who 58 61 3653 3656 O
are 62 65 3657 3660 O
up 66 68 3661 3663 O
in 69 71 3664 3666 O
a 72 73 3667 3668 O
wheelchair 74 84 3669 3679 O
, 84 85 3679 3680 O
will 86 90 3681 3685 O
be 91 93 3686 3688 O
considered 94 104 3689 3699 O
to 105 107 3700 3702 O
be 108 110 3703 3705 O
ambulatory 111 121 3706 3716 O
for 122 125 3717 3720 O
the 126 129 3721 3724 O
purpose 130 137 3725 3732 O
of 138 140 3733 3735 O
assessing 141 150 3736 3745 O
the 151 154 3746 3749 O
performance 155 166 3750 3761 O
score 167 172 3762 3767 O

Patients 0 8 3768 3776 O
with 9 13 3777 3781 O
newly 14 19 3782 3787 O
diagnosed 20 29 3788 3797 O
AT 30 32 3798 3800 B-cancer
/ 32 33 3800 3801 I-cancer
RT 33 35 3801 3803 I-cancer

Patients 0 8 3804 3812 O
with 9 13 3813 3817 O
newly 14 19 3818 3823 O
diagnosed 20 29 3824 3833 O
AT 30 32 3834 3836 B-cancer
/ 32 33 3836 3837 I-cancer
RT 33 35 3837 3839 I-cancer
and 36 39 3840 3843 O
synchronous 40 51 3844 3855 O
extra 52 57 3856 3861 B-cancer
- 57 58 3861 3862 I-cancer
CNS 58 61 3862 3865 I-cancer
MRT 62 65 3866 3869 I-cancer

Patients 0 8 3870 3878 O
with 9 13 3879 3883 O
progressive 14 25 3884 3895 O
synchronous 26 37 3896 3907 O
/ 37 38 3907 3908 O
metachronous 38 50 3908 3920 B-cancer
AT 51 53 3921 3923 O
/ 53 54 3923 3924 O
RT 54 56 3924 3926 O
and 57 60 3927 3930 O
MRT 61 64 3931 3934 O
will 65 69 3935 3939 O
be 70 72 3940 3942 O
eligible 73 81 3943 3951 O
for 82 85 3952 3955 O
stratum 86 93 3956 3963 O
A3 94 96 3964 3966 O

Patients 0 8 3967 3975 O
with 9 13 3976 3980 O
recurrent 14 23 3981 3990 O
or 24 26 3991 3993 O
progressive 27 38 3994 4005 O
AT 39 41 4006 4008 B-clinical_variable
/ 41 42 4008 4009 O
RT 42 44 4009 4011 B-clinical_variable
/ 44 45 4011 4012 O
MRT 45 48 4012 4015 B-clinical_variable
( 49 50 4016 4017 O
either 50 56 4017 4023 O
CNS 57 60 4024 4027 O
and/or 61 67 4028 4034 O
extra 68 73 4035 4040 O
- 73 74 4040 4041 O
CNS 74 77 4041 4044 O
) 77 78 4044 4045 O
with 79 83 4046 4050 O
radiographically 84 100 4051 4067 O
measurable 101 111 4068 4078 O
disease 112 119 4079 4086 O
as 120 122 4087 4089 O
defined 123 130 4090 4097 O
by 131 133 4098 4100 O
at 134 136 4101 4103 O
least 137 142 4104 4109 O
1 143 144 4110 4111 B-lower_bound
lesion 145 151 4112 4118 O
that 152 156 4119 4123 O
can 157 160 4124 4127 O
be 161 163 4128 4130 O
measured 164 172 4131 4139 O
in 173 175 4140 4142 O
2 176 177 4143 4144 O
dimensions 178 188 4145 4155 O
or 189 191 4156 4158 O
with 192 196 4159 4163 O
tumor 197 202 4164 4169 B-cancer
cells 203 208 4170 4175 O
present 209 216 4176 4183 O
in 217 219 4184 4186 O
the 220 223 4187 4190 O
CSF 224 227 4191 4194 B-clinical_variable
taken 228 233 4195 4200 O
within 234 240 4201 4207 O
2 241 242 4208 4209 B-upper_bound
weeks 243 248 4210 4215 I-upper_bound
prior 249 254 4216 4221 I-upper_bound
to 255 257 4222 4224 O
enrollment 258 268 4225 4235 O

Performance 0 11 4236 4247 O
status 12 18 4248 4254 O
defined 19 26 4255 4262 O
by 27 29 4263 4265 O
Karnofsky 30 39 4266 4275 B-clinical_variable
or 40 42 4276 4278 O
Lansky 43 49 4279 4285 B-clinical_variable
> 50 51 4286 4287 O
30 52 54 4288 4290 B-lower_bound
( 55 56 4291 4292 O
except 56 62 4292 4298 O
for 63 66 4299 4302 O
patients 67 75 4303 4311 O
with 76 80 4312 4316 O
posterior 81 90 4317 4326 B-chronic_disease
fossa 91 96 4327 4332 I-chronic_disease
syndrome 97 105 4333 4341 I-chronic_disease
) 105 106 4341 4342 O

Performance 0 11 4343 4354 O
status 12 18 4355 4361 O
defined 19 26 4362 4369 O
by 27 29 4370 4372 O
Karnofsky 30 39 4373 4382 B-clinical_variable
or 40 42 4383 4385 O
Lansky 43 49 4386 4392 B-clinical_variable
> 50 51 4393 4394 O
60 52 54 4395 4397 B-lower_bound
( 55 56 4398 4399 O
except 56 62 4399 4405 O
for 63 66 4406 4409 O
patients 67 75 4410 4418 O
with 76 80 4419 4423 O
posterior 81 90 4424 4433 B-chronic_disease
fossa 91 96 4434 4439 I-chronic_disease
syndrome 97 105 4440 4448 I-chronic_disease
) 105 106 4448 4449 O

Presence 0 8 4450 4458 O
of 9 11 4459 4461 O
an 12 14 4462 4464 O
active 15 21 4465 4471 O
, 21 22 4471 4472 O
uncontrolled 23 35 4473 4485 B-chronic_disease
infection 36 45 4486 4495 I-chronic_disease

Radiation 0 9 4496 4505 B-treatment
therapy 10 17 4506 4513 I-treatment
: 17 18 4513 4514 O
at 19 21 4515 4517 O
least 22 27 4518 4523 O
3 28 29 4524 4525 B-lower_bound
months 30 36 4526 4532 I-lower_bound
must 37 41 4533 4537 O
have 42 46 4538 4542 O
elapsed 47 54 4543 4550 O
since 55 60 4551 4556 O
any 61 64 4557 4560 O
irradiation 65 76 4561 4572 O
unless 77 83 4573 4579 O
measurable 84 94 4580 4590 O
disease 95 102 4591 4598 O
progression 103 114 4599 4610 O
occurs 115 121 4611 4617 O
at 122 124 4618 4620 O
a 125 126 4621 4622 O
site 127 131 4623 4627 O
separate 132 140 4628 4636 O
from 141 145 4637 4641 O
the 146 149 4642 4645 O
irradiated 150 160 4646 4656 O
area 161 165 4657 4661 O
and 166 169 4662 4665 O
the 170 173 4666 4669 O
patient 174 181 4670 4677 O
has 182 185 4678 4681 O
recovered 186 195 4682 4691 O
from 196 200 4692 4696 O
toxicities 201 211 4697 4707 O
associated 212 222 4708 4718 O
with 223 227 4719 4723 O
radiation 228 237 4724 4733 B-treatment
therapy 238 245 4734 4741 I-treatment

Requirement 0 11 4742 4753 O
for 12 15 4754 4757 O
constant 16 24 4758 4766 O
administration 25 39 4767 4781 O
of 40 42 4782 4784 O
proton 43 49 4785 4791 B-treatment
- 49 50 4791 4792 I-treatment
pump 50 54 4792 4796 I-treatment
inhibitor 55 64 4797 4806 I-treatment
, 64 65 4806 4807 O
H2 66 68 4808 4810 B-treatment
antagonist 69 79 4811 4821 I-treatment
, 79 80 4821 4822 O
or 81 83 4823 4825 O
pancreatic 84 94 4826 4836 B-treatment
enzymes 95 102 4837 4844 I-treatment

Stable 0 6 4845 4851 O
neurologic 7 17 4852 4862 B-chronic_disease
deficits 18 26 4863 4871 I-chronic_disease
on 27 29 4872 4874 O
a 30 31 4875 4876 O
stable 32 38 4877 4883 O
dose 39 43 4884 4888 O
of 44 46 4889 4891 O
corticosteroids 47 62 4892 4907 B-treatment
( 63 64 4908 4909 O
if 64 66 4909 4911 O
applicable 67 77 4912 4922 O
) 77 78 4922 4923 O
for 79 82 4924 4927 O
at 83 85 4928 4930 O
least 86 91 4931 4936 O
1 92 93 4937 4938 B-upper_bound
week 94 98 4939 4943 I-upper_bound
before 99 105 4944 4950 I-upper_bound
study 106 111 4951 4956 O
enrollment 112 122 4957 4967 O

Treatment 0 9 4968 4977 B-treatment
with 10 14 4978 4982 I-treatment
clinically 15 25 4983 4993 I-treatment
significant 26 37 4994 5005 I-treatment
enzyme 38 44 5006 5012 I-treatment
inducers 45 53 5013 5021 I-treatment
, 53 54 5021 5022 O
such 55 59 5023 5027 O
as 60 62 5028 5030 O
the 63 66 5031 5034 O
enzyme 67 73 5035 5041 B-treatment
- 73 74 5041 5042 I-treatment
inducing 74 82 5042 5050 I-treatment
antiepileptic 83 96 5051 5064 I-treatment
drugs 97 102 5065 5070 I-treatment
phenytoin 103 112 5071 5080 I-treatment
, 112 113 5080 5081 O
carbamazepine 114 127 5082 5095 B-treatment
or 128 130 5096 5098 O
phenobarbital 131 144 5099 5112 B-treatment
, 144 145 5112 5113 O
or 146 148 5114 5116 O
with 149 153 5117 5121 O
rifampin 154 162 5122 5130 B-treatment
, 162 163 5130 5131 O
rifabutin 164 173 5132 5141 B-treatment
, 173 174 5141 5142 O
rifapentine 175 186 5143 5154 B-treatment
, 186 187 5154 5155 O
or 188 190 5156 5158 O
St. 191 194 5159 5162 B-treatment
John 195 199 5163 5167 I-treatment
's 199 201 5167 5169 I-treatment
wort 202 206 5170 5174 I-treatment
within 207 213 5175 5181 O
7 214 215 5182 5183 B-upper_bound
days 216 220 5184 5188 I-upper_bound
prior 221 226 5189 5194 I-upper_bound
to 227 229 5195 5197 O
initiation 230 240 5198 5208 O
of 241 243 5209 5211 O
alisertib 244 253 5212 5221 B-treatment

Use 0 3 5222 5225 O
Karnofsky 4 13 5226 5235 B-clinical_variable
for 14 17 5236 5239 O
patients 18 26 5240 5248 O
> 27 28 5249 5250 O
16 29 31 5251 5253 O
years 32 37 5254 5259 O
and 38 41 5260 5263 O
Lansky 42 48 5264 5270 B-clinical_variable
for 49 52 5271 5274 O
patients 53 61 5275 5283 O
< 62 63 5284 5285 O
16 64 66 5286 5288 O
years 67 72 5289 5294 O

at 0 2 5295 5297 O
least 3 8 5298 5303 O
10 9 11 5304 5306 B-lower_bound
- 11 12 5306 5307 I-lower_bound
years 12 17 5307 5312 I-lower_bound
- 17 18 5312 5313 O
old 18 21 5313 5316 O

partial 0 7 5317 5324 O
gastrectomy 8 19 5325 5336 B-treatment
, 19 20 5336 5337 O
history 21 28 5338 5345 O
of 29 31 5346 5348 O
small 32 37 5349 5354 O
intestine 38 47 5355 5364 O
surgery 48 55 5365 5372 B-treatment
, 55 56 5372 5373 O
and 57 60 5374 5377 O
celiac 61 67 5378 5384 B-chronic_disease
disease 68 75 5385 5392 I-chronic_disease

post 0 4 5393 5397 O
- 4 5 5397 5398 O
menarchal 5 14 5398 5407 O
must 15 19 5408 5412 O
have 20 24 5413 5417 O
a 25 26 5418 5419 O
negative 27 35 5420 5428 O
serum 36 41 5429 5434 O
or 42 44 5435 5437 O
urine 45 50 5438 5443 O
pregnancy 51 60 5444 5453 B-pregnancy
test 61 65 5454 5458 O
prior 66 71 5459 5464 O
to 72 74 5465 5467 O
enrollment 75 85 5468 5478 O

